Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGF vs FUV in Stable COPD Patients
NCT06905483Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Breztri Aerosphere, fluticasone furoate + umeclidinium bromide + vilanterol trifenatate in chronic obstructive pulmonary disease (COPD), sponsored by Thammasat University. Started Apr 2025; status: completed.
02
Drugs
Breztri Aerospherefluticasone furoate + umeclidinium bromide + vilanterol trifenatate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06905483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905483.